CCP
BSX icon

Clarity Capital Partners’s Boston Scientific BSX Stock Holding History

Clarity Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,778
Closed -$381K – 115
2025
Q1 		$381K Buy
3,778
+622
+20% +$62.6K 0.15% 70
2024
Q4 		$282K Buy
3,156
+661
+26% +$58.2K 0.15% 101
2024
Q3 		$209K Sell
2,495
-242
-9% -$19.1K 0.12% 113
2024
Q2 		$211K Buy
+2,737
New +$200K 0.13% 106

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clarity Capital Partners's BSX Position: Q2 2025 in Review

Clarity Capital Partners sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 3,778 shares — an estimated $381K sold.

Clarity Capital Partners first reported a position in BSX in Q2 2024 and held it in 4 quarters. The position peaked at $381K in Q1 2025. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Clarity Capital Partners reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
  • Clarity Capital Partners sold 3,778 Boston Scientific shares in Q2 2025, an estimated $381K.
  • Clarity Capital Partners first reported a position in Boston Scientific in Q2 2024 and held it in 4 quarters.
  • Clarity Capital Partners's Boston Scientific position peaked at $381K in Q1 2025.
  • 1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Clarity Capital Partners's 13F filing for Q2 2025, filed 21 Jul 2025.